Memory Enhancement by Multidomain Group Cognitive Training in Patients with Parkinson's Disease and Mild Cognitive Impairment: Long-term Effects of a Multicenter Randomized Controlled Trial
Authors
Affiliations
Background: Meta-analyses indicate positive effects of cognitive training (CT) in patients with Parkinson's disease (PD), however, most previous studies had small sample sizes and did not evaluate long-term follow-up. Therefore, a multicenter randomized controlled, single-blinded trial (Train-ParC study) was conducted to examine CT effects in PD patients with mild cognitive impairment (PD-MCI). Immediately after CT, an enhancement of executive functions was demonstrated. Here, we present the long-term results 6 and 12 months after CT.
Methods: At baseline, 64 PD-MCI patients were randomized to a multidomain CT group (n = 33) or to a low-intensity physical activity training control group (PT) (n = 31). Both interventions included 90 min training sessions twice a week for 6 weeks. 54 patients completed the 6 months (CT: n = 28, PT: n = 26) and 49 patients the 12 months follow-up assessment (CT: n = 25, PT: n = 24). Primary study outcomes were memory and executive functioning composite scores. Mixed repeated measures ANOVAs, post-hoc t tests and multiple regression analyses were conducted.
Results: We found a significant time x group interaction effect for the memory composite score (p = 0.006, η = 0.214), but not for the executive composite score (p = 0.967, η = 0.002). Post-hoc t tests revealed significant verbal and nonverbal memory improvements from pre-intervention to 6 months, but not to 12 months follow-up assessment in the CT group. No significant predictors were found for predicting memory improvement after CT.
Conclusions: This study provides Class 1 evidence that multidomain CT enhances memory functioning in PD-MCI after 6 months but not after 12 months, whereas executive functioning did not change in the long-term.
Clinical Trial Registration: German Clinical Trials Register (ID: DRKS00010186), 21.3.2016 (The study registration is outlined as retrospective due to an administrative delay. The first patient was enrolled three months after the registration process was started. A formal confirmation of this process from the German Clinical Trials Register can be obtained from the authors.).
Pigott J, Armstrong M, Tabassum N, Davies N, Schrag A Parkinsons Dis. 2024; 2024:3654652.
PMID: 39588065 PMC: 11588407. DOI: 10.1155/2024/3654652.
Wu X, Shi M, Lian Y, Zhang H BMC Neurol. 2024; 24(1):352.
PMID: 39300337 PMC: 11411832. DOI: 10.1186/s12883-024-03859-x.
Trenado C, Trauberg P, Elben S, Dimenshteyn K, Folkerts A, Witt K Neurol Res Pract. 2023; 5(1):46.
PMID: 37705108 PMC: 10500911. DOI: 10.1186/s42466-023-00273-5.
Wang Y, Sun X, Li F, Li Q, Jin Y Front Aging Neurosci. 2022; 14:1050715.
PMID: 36438007 PMC: 9691406. DOI: 10.3389/fnagi.2022.1050715.